Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
New member
Sign up for FREE
New customer
Discover our services
Settings
Settings
Dynamic quotes 
OFFON

MarketScreener Homepage  >  Equities  >  Australian Stock Exchange  >  CSL Limited    CSL   AU000000CSL8

CSL LIMITED

(CSL)
  Report
SummaryChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
Upcoming events on CSL LIMITED
02/16/21 Interim 2021 Earnings Release
08/18/21 FY 2021 Earnings Release (Projected)
10/12/21 Annual General Meeting
02/16/22 Interim 2022 Earnings Release (Projected)
Past events on CSL LIMITED
10/21/20 Infectious Disease Society of America ID Week Meeting
10/19/20 | 06:00pm R&D Day
10/13/20 | 07:00pm Annual General Meeting
09/10/20 Ex-dividend day for final dividend
Upcoming sector events for CSL LIMITED
01/22/21 | 01:00am WALVAX BIOTECHNOLOGY CO., LTD. : Extraordinary Shareholders Meeting
01/22/21 | 02:30am BETTA PHARMACEUTICALS CO., LTD. : Extraordinary Shareholders Meeting
01/26/21 | 08:00am NOVARTIS AG : FY 2020 Earnings Call
01/26/21 | 08:30am JOHNSON & JOHNSON : FY 2020 Earnings Call
More events
Past sector events for CSL LIMITED
01/21/21 | 01:30am SHENZHEN SALUBRIS PHARMACEUTICALS CO., LTD. : Extraordinary Shareholders Meeting
01/19/21 BRIDGEBIO PHARMA, INC. : Extraordinary Shareholders Meeting - M&A Vote
01/17/21 | 03:30pm ROCHE HOLDING AG : Gastrointestinal Cancers Symposium
01/15/21 | 04:30pm EISAI CO., LTD. : American society of clinical oncology virtual gastrointestinal cancers symposium - abstract #: 230
Annual publications
Annual results201620172018201920202021 (e)
Sales
M $
Released
Forecast
Spread
6 115
6 249
-2,1%
6 923
6 877
0,66%
7 915
7 730
2,4%
8 539
8 493
0,53%
9 151
9 224
-0,79%

10 127
Operating income
(EBITDA)
M $
Released
Forecast
Spread
1 749
1 836
-4,7%
2 048
2 096
-2,3%
2 677
2 596
3,1%
2 879
2 911
-1,1%
3 136
3 204
-2,1%

3 440
Operating profit
(EBIT)
M $
Released
Forecast
Spread
1 529
1 630
-6,2%
1 769
1 835
-3,6%
2 380
2 296
3,7%
2 504
2 575
-2,8%
2 717
2 781
-2,3%

2 982
Pre-Tax Profit
(EBT)
M $
Released
Forecast
Spread
1 556
1 663
-6,4%
1 690
1 755
-3,7%
2 281
2 191
4,1%
2 341
2 420
-3,3%
2 573
2 651
-3,0%

2 820
Net income
M $
Released
Forecast
Spread
1 242
1 279
-2,9%
1 337
1 358
-1,5%
1 729
1 704
1,4%
1 919
1 908
0,57%
2 103
2 115
-0,61%

2 254
EPS
$
Released
Forecast
Spread
2,68
2,79
-3,9%
2,94
2,98
-1,6%
3,81
3,78
0,81%
4,23
4,21
0,43%
4,62
4,65
-0,84%

4,95
Announcement Date08/16/201608/15/201708/14/201808/13/201908/18/2020

Quarterly publications
Previous periodNext period
Quarterly results2018 S22019 S12019 S22020 S12020 S22021 S1 (e)
Sales
M $
Released
Forecast
Spread
3 768
3 554
6,0%
4 505
4 514
-0,20%
4 034
4 024
0,24%
4 911
4 821
1,9%
4 240
4 347
-2,4%

5 509
Operating income
(EBITDA)
M $
Released
Forecast
Spread
1 060
975
8,7%
1 719
1 768
-2,8%
1 160
1 163
-0,26%
1 836
1 896
-3,1%
1 300
1 281
1,5%

2 129
Operating profit
(EBIT)
M $
Released
Forecast
Spread
904
837
8,0%
1 553
1 599
-2,9%
951
1 093
-13%
1 632
1 689
-3,4%
1 085
1 079
0,51%

1 920
Pre-Tax Profit
(EBT)
M $
Released
Forecast
Spread
857
749
14%
1 460
1 569
-6,9%
881
947
-7,0%
1 561
1 611
-3,1%
1 011
1 007
0,44%

1 843
Net income
M $
Released
Forecast
Spread
643
631
2,0%
1 161
1 202
-3,4%
758
751
0,87%
1 248
1 296
-3,7%
855
805
6,1%

1 448
EPS
Released
Forecast
Spread
1,41
1,39
1,4%
2,56
2,65
-3,5%
1,67
1,67
0,04%
2,74
2,89
-5,2%
1,88
1,93
-2,8%

3,18
Announcement Date08/14/201802/12/201908/13/201902/11/202008/18/2020

Financial data source
© 2021 S&P Global Market Intelligence
© 2021 Factset
Net sales (Year) - Rate of surprise
EPS (Year) - Rate of surprise
Net sales (Quarter) - Rate of surprise
EPS (Quarter) - Rate of surprise